Author Topic: Ray peat website  (Read 236 times)

0 Members and 1 Guest are viewing this topic.

Offline The_Return_Of_BTK

  • Senior Member
  • *****
  • Posts: 295
  • Gender: Male
  • Member of the UK Psoriasis Help Forum
  • View Gallery
Ray peat website
« on: April 20, 2012, 09:49:45 PM »
I have found along with  many others Rays website very interesting.I have sent him quite a few questions and had replies within 24 hours.i asked him 1 about psoriasis.this was his reply


Have you tried eliminating grains and other foods
that can promote intestinal inflammation? Have
you tried taking a vitamin D supplement? Coffee,
and topical caffeine, topical niacinamide,
vitamin K, and lots of calcium sometimes help. A
thyroid supplement is sometimes all it takes.


J Dermatolog Treat. 2005;16(4):234-7.
Evaluation of the efficacy of topical caffeine in
the treatment of psoriasis vulgaris.
Vali A, Asilian A, Khalesi E, Khoddami L, Shahtalebi M, Mohammady M.
Department of Dermatology, Isfahan University of Medical Sciences (IUMS), Iran.
You are not allowed to view links. Register or Login
BACKGROUND: Psoriasis is a common disease which often requires long-term
maintenance therapy. In psoriatic epidermis, the level of cyclic adenosine
monophosphate (cAMP) decreases. It has been reported that beta-blockers
exacerbate existing psoriatic plaque and decrease the concentration of
intracellular cAMP. Caffeine is a methylxanthine
that inhibits phosphodiesterase
enzyme and results in a higher concentration of intracellular cAMP. OBJECTIVE:
Evaluation of the efficacy of topical caffeine
10% in the treatment of psoriasis.
PATIENTS AND METHODS: The patients were treated by topical application of 10%
caffeine or placebo three times per day on the right or left side of the body
(randomly selected by flipping a coin). Thirty-nine patients with stable plaque
psoriasis were included in a randomized, double-blind, placebo-controlled,
right/left comparison. The patients visited every other week for a period of 8
weeks. Their Psoriatic Area and Severity Index (PASI) scores were assessed at
each visit. RESULTS: The reductions in PASI scores measured at the four visits
for the caffeine-treated group were 2.64+/-2.89, 4.47+/-3.62, 5.73+/-4.16,
6.58+/-4.40 and for the placebo-treated group the values were 1.45+/-2.32,
3.04+/-2.68, 4.02+/-3.36, 4.43+/-3.45,
respectively. Comparing the corresponding
results of the two groups, p values at the
second, fourth, sixth and eighth week
were 0.081, 0.083, 0.079 and 0.047, respectively. Based on presented p values,
the treatment with caffeine is more effective than with placebo after 8 weeks
(p<0.05), and the only side effect of caffeine is
mild itching. CONCLUSION: Based
on the results of the trial, topical caffeine is an effective, safe and
inexpensive treatment for psoriasis, with a delay in action.
Randomized Controlled Trial

Skin Pharmacol. 1991;4(4):286-90.
Xanthines inhibit 3T3 fibroblast proliferation.
Levi-Schaffer F, Touitou E.
Department of Pharmacology, School of Pharmacy, Hebrew University of Jerusalem,
Israel.
It is believed that xanthines can inhibit cell proliferation by elevating
intracellular cAMP. Therefore, these compounds can be useful in
hyperproliferative disorders. Our aim was to
assess the efficacy of theophylline,
caffeine and dyphylline on 3T3 fibroblast proliferation. 3T3 subconfluent
cultures were incubated for 3 days with the
xanthine derivatives (1 mM-1 microM).
At 1 and 0.1 mM the three derivatives exhibited marked inhibition of fibroblast
proliferation. Theophylline and caffeine were more potent than dyphylline. At a
concentration of 1 mM, the three xanthine derivatives also inhibited
proliferation of psoriatic dermal fibroblast,
albeit to a lower extent. Caffeine
was the most active compound followed by
theophylline and dyphylline. We conclude
that xanthine derivatives are good candidates for use as fibroblast
antiproliferative drugs. We also conclude that 3T3 fibroblasts appear to be a
valid system for the pharmacological screening of fibroblast antiproliferative
drugs.


Offline The_Return_Of_BTK

  • Senior Member
  • *****
  • Posts: 295
  • Gender: Male
  • Member of the UK Psoriasis Help Forum
  • View Gallery
Re: Ray peat website
« Reply #1 on: April 20, 2012, 09:51:25 PM »
Skin Pharmacol. 1996;9(1):53-9.
Diethylene glycol monoethyl ether (Transcutol) displays antiproliferative
properties alone and in combination with xanthines.
Levi-Schaffer F, Dayan N, Touitou E.
Department of Pharmacology, Hebrew University, Jerusalem, Israel.
In the present study we have investigated the effects of diethylene glycol
monoethyl ether (Transcutol) in combination with theophylline, caffeine and
dyphylline and alone on 3T3 mouse fibroblast
proliferation. These three xanthines
(1-0.01 mM) inhibited fibroblast proliferation by
themselves. Enhancement of the
effect was detected by addition of 1 and 0.1 mM
Transcutol. Transcutol alone also
displayed a dose-dependent inhibition (2-0.01 mM) of both 3T3 and human normal
and psoriatic fibroblasts, although normal human fibroblasts were the least
sensitive to Transcutol antiproliferative activity. Transcutol was assessed for
its antiproliferative effects on YAC lymphoma and P-815 mastocytoma human cell
lines. Transcutol inhibited cell proliferation of both these cell lines, being
more effective towards P-815 mastocytoma (at 2 mM it displayed 3.95-fold vs.
2.4-fold inhibition towards YAC lymphoma). In conclusion, we have shown that
Transcutol has antiproliferative effects on 3T3 murine, human normal and
psoriatic fibroblasts and tumour cell lines. In addition it enhances xanthine
antiproliferative effects on 3T3 fibroblasts. Therefore it might be a useful
topical drug alone or in combination with xanthines in the treatment of skin
hyperproliferative disorders.



Offline The_Return_Of_BTK

  • Senior Member
  • *****
  • Posts: 295
  • Gender: Male
  • Member of the UK Psoriasis Help Forum
  • View Gallery
Re: Ray peat website
« Reply #2 on: April 20, 2012, 09:52:50 PM »
.

FASEB J. 2003 Aug;17(11):1377-9.
Nicotinamide: a potential addition to the anti-psoriatic weaponry.
Namazi MR.
Dermatology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
You are not allowed to view links. Register or Login
Psoriasis is an inflammatory disorder characterized by a T helper type 1 cell
cytokine pattern. Increased expression of adhesion molecules, prominent
neutrophil accumulation, and increased production of nitric oxide are
characteristics of this disorder. Moreover,
histamine and proteases are supposed
to participate in the pathogenesis of psoriasis.
Nicotinamide is an inhibitor of
poly (ADP-ribose) polymerase-1 (PARP-1) that, through enhancement of nuclear
kappa B-mediated transcription, plays a pivotal role in the expression of
inflammatory cytokines, chemokines, adhesion molecules, and inflammatory
mediators. Through interaction with CD38 and inhibition of IL-1, IL-12, and
TNF-alpha production, nicotinamide produces a mild TH2 bias. Nicotinamide is a
potent phosphodiesterase inhibitor and suppresses
neutrophil chemotaxis and mast
cell histamine release. It inhibits nitric oxide synthase mRNA induction and
suppresses antigen-induced lymphocyte
transformation. Nicotinamide increases the
biosynthesis of ceramides, which upon degradation produce sphingosine.
Sphingosine inhibits protein kinase C (PKC) and decreases basal cell
proliferation dependent on PKC. Taken together, it can be reasoned that
nicotinamide could be a useful addition to anti-psoriatic armamentarium. The
combination of nicotinamide and thalidomide or methotrexate provided a powerful
synergistic inhibition of murine collagen-induced arthritis. Nicotinamide
decreased the methotrexate-induced hepatotoxicity. The above combinations may
prove to have a powerful anti-psoriatic effect as
well. As PARP inhibitors could
exert anti-retroviral effect, nicotinamide could
also be of special value in the
treatment of HIV-infected psoriatics.
J Am Acad Dermatol. 2010 Nov;63(5):775-81.
Pilot, multicenter, double-blind, randomized placebo-controlled bilateral
comparative study of a combination of calcipotriene and nicotinamide for the
treatment of psoriasis.

Offline The_Return_Of_BTK

  • Senior Member
  • *****
  • Posts: 295
  • Gender: Male
  • Member of the UK Psoriasis Help Forum
  • View Gallery
Re: Ray peat website
« Reply #3 on: April 20, 2012, 09:53:01 PM »
Biochem J. 2001 Feb 1;353(Pt 3):459-66.
Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis?
Hanselmann C, Mauch C, Werner S.
Institute of Cell Biology, Swiss Federal Institute of Technology, Hönggerberg,
CH-8093 Zürich, Switzerland.
Haem oxygenase (HO) is the rate-limiting enzyme in the degradation of haem. In
addition to its obvious role in iron metabolism,
a series of findings indicate an
important role for HO in cellular protection against oxidative stress. This
effect might be of particular importance during wound healing and also in
inflammatory disease. Therefore we determined the expression of the two HO
isoenzymes, HO-1 and HO-2, during the healing process of full-thickness
excisional wounds in mice. We show a remarkable induction of HO-1 mRNA and
protein expression within three days after skin
injury. After completion of wound
healing, HO-1 expression declined to basal levels. By contrast, expression of
HO-2 was not significantly modulated by skin injury. In situ hybridization and
immunohistochemistry revealed high HO-1 expression in inflammatory cells of the
granulation tissue and in keratinocytes of the hyperproliferative epithelium. A
strong overexpression of HO-1 was also observed
in the skin of patients suffering
from the inflammatory skin disease psoriasis. In
addition, HO-2 mRNA levels were
increased in the skin of psoriatic patients. Similar to wounded skin,
inflammatory cells and keratinocytes of the hyperthickened epidermis were the
major producers of HO-1 in psoriatic skin. In vitro studies with cultured
keratinocytes revealed a potential role for reactive oxygen species (ROS), but
not for growth factors and pro-inflammatory cytokines, as inducers of HO-1
expression in inflamed skin. Our findings suggest a novel role for HO in wound
healing and inflammatory skin disease, where it might be involved in haem
degradation and in the protection of cells from the toxic effects of ROS.
J Eur Acad Dermatol Venereol. 2003 Nov;17(6):663-9.
Antioxidant activity, lipid peroxidation and skin diseases. What's new.
Briganti S, Picardo M.
Cutaneous Physiopathology Laboratory, San Gallicano Dermatological Institute,
25/A Via S. Gallicano, 00153-Rome, Italy. You are not allowed to view links. Register or Login
Due to its interface function between the body and the environment, the skin is
chronically exposed to both endogenous and environmental pro-oxidant agents,
leading to the harmful generation of reactive oxygen species (ROS). There is
compelling evidence that oxidative stress is involved in the damage of cellular
constituents, such as DNA, cell membrane lipids
or proteins. To protect the skin
against the over-load of oxidant species, it
contains a well-organised system of
both chemical and enzymatic antioxidant which are able to work in a synergistic
manner. Skin antioxidant network protects cells against oxidative injury and
prevent the production of oxidation products, such as 4-hydroxy-2-nonenal or
malonaldehyde, which are able to induce protein damage, apoptosis or release of
pro-inflammatory mediators, such as cytokines. When oxidative stress overwhelms
the skin antioxidant capacity the subsequent modification of cellular redox
apparatus leads to an alteration of cell homeostasis and a generation of
degenerative processes. Topical application or oral administration of
antioxidants has been recently suggested as preventive therapy for skin
photoaging and UV-induced cancer. The recognition that ROS can act as second
messengers in the induction of several biological responses, such as the
activation of NF-kB or AP-1, the generation of cytokines, the modulation of
signalling pathways, etc., has led many researchers to focus on the possible
effects of antioxidants in many pathological
processes. The recent demonstration
that the peroxisome proliferators-activated
receptors, whose natural ligands are
polyunsaturated fatty acids and theirs oxidation
products, have a central role in
the induction of some skin diseases, such as
psoriasis or acne, has indicated new
links between free radicals and skin inflammation. Based on these findings, the
review summarises the possible correlations
between antioxidant imbalance, lipid
oxidative breakage and skin diseases, from both a pathological and therapeutic
points of view